Kirkland Represents Patient Square Capital on Acquisition of Radius Health for $890 Million

Kirkland & Ellis advised Patient Square Capital, a dedicated health care investment firm, on its acquisition of Radius Health, Inc. alongside Gurnet Point Capital for approximately $890 million. Radius Health is a global biopharmaceutical company focused on addressing unmet medical needs in the areas of bone health, neuro-orphan diseases, and oncology. The transaction is expected to close in the third quarter of 2022, subject to customary closing conditions.     

Read Radius Health's press release

The Kirkland team was led by corporate partners Maggie Flores, Michael Weisser, Daniel Wolf and Shaun Mathew and associates Evan Johnson and Keli Huang, debt finance partner Jason Kanner, and tax partner Mark Schwed.